MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection.

Marakasova, Ekaterina; Baranova, Ancha

Marakasova, Ekaterina; Baranova, Ancha.

Marakasova E; School of Systems Biology, George Mason University (GMU), Fairfax, Virginia, USA.
Baranova A; School of Systems Biology, George Mason University (GMU), Fairfax, Virginia, USA abaranov@gmu.edu.

mBio ; 12(1)2021 02 02.

Article in English | MEDLINE | ID: covidwho-1061068

Subject(s)

COVID-19; Measles; Mumps; Rubella; Complement Activation; Humans; Measles/prevention & control; Measles-Mumps-Rubella Vaccine; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rubella / COVID-19 / Measles / Mumps Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: MBio.03447-20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google